The exterior of Brigham and Women's Hospital / Boston Lying-in Hospital Credit: Jim McIntosh
Until two years ago, people in China who wanted medical care from Brigham and Women’s Hospital, an affiliate of Harvard University, had to take a 7,000-mile plane ride to Boston. That all changed in 2018, when the Boao Evergrande International Hospital opened on China’s Hainan island. The facility, a Brigham partnership with one of China’s biggest property developers, is focused initially on treating breast cancer.
Brigham is only one of a growing group of world-renowned American hospitals planting their flags in China. They are tapping into one of the world’s fastest growing health-care markets, one that is on track to spend $2.4 trillion annually on medical services by the year 2040, according to China’s National Health and Family Planning Commission.
The Cleveland Clinic has struck a deal with Luye Medical, a Singapore-based company, to set up a hospital in Shanghai. Mount Sinai Health System in New York has agreed to advise Taikang Healthcare on a 500-bed hosp
Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from David Barboza, Pulitzer Prize-winning former Shanghai correspondent for The New York Times.
A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.
Brands have long relied on social auditing companies to monitor their supply chains in China. But between the industry’s own flaws and a changing political environment in China, many say these reports aren't reliable. With the Uyghur Forced Labor Prevention Act now going into effect, this lack of trust in the industry leaves many global companies — and those hoping to hold them accountable — in a tricky spot.
A key figure in the Trump administration, the former reporter and Marine talks about the reality of the Chinese Communist Party's ambitions, the value of concrete actions vs. rhetoric, how Xi was flummoxed by Trump,...
